StockMacro
Menu

Ingredion

$89.19 -14% in 6 monthsMarket cap $5.6B

INGR on XNYS, Consumer Staples, Ingredion Incorporated, job postings

Measures activity, not value. Not investment advice.

Net income fell 15% over 12 months as revenue slipped 1.0% and shares lost 16% in a year.

  • BadShort interest at 7.3% of shares, 6.4 days to cover

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Ingredion provides ingredients to the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company sells specialty ingredients, including starch-based texturizers and natural alternative sweeteners such as stevia. Ingredion also sells commodity ingredients that include sweeteners, such as high-fructose corn syrup, and starches, such as those used for sustainable packaging, as well as plant-based proteins. The company plans to acquire Tate & Lyle in an all-cash deal that should close in 2027.

Industry
Grain mill products (Consumer Staples)
Employees
11,200
Website
ingredion.com
Listed
NYSE, US
Last results
5 Nov 2026
Next results
expected around 2 Feb 2027 (an estimate: a year ago it reported on 3 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.8B, net income $142.0M.
Quarter to 31 Dec 2021: revenue $1.8B, net income $67.0MQuarter to 31 Dec 2021: revenue $1.8B, net income $67.0MQuarter to 31 Mar 2022: revenue $1.9B, net income $130.0MQuarter to 31 Mar 2022: revenue $1.9B, net income $130.0MQuarter to 30 Jun 2022: revenue $2.0B, net income $142.0MQuarter to 30 Jun 2022: revenue $2.0B, net income $142.0MQuarter to 30 Sep 2022: revenue $2.0B, net income $106.0MQuarter to 30 Sep 2022: revenue $2.0B, net income $106.0MQuarter to 31 Dec 2022: revenue $2.0B, net income $114.0MQuarter to 31 Dec 2022: revenue $2.0B, net income $114.0MQuarter to 31 Mar 2023: revenue $2.1B, net income $191.0MQuarter to 31 Mar 2023: revenue $2.1B, net income $191.0MQuarter to 30 Jun 2023: revenue $2.1B, net income $163.0MQuarter to 30 Jun 2023: revenue $2.1B, net income $163.0MQuarter to 30 Sep 2023: revenue $2.0B, net income $158.0MQuarter to 30 Sep 2023: revenue $2.0B, net income $158.0MQuarter to 31 Dec 2023: revenue $1.9B, net income $131.0MQuarter to 31 Dec 2023: revenue $1.9B, net income $131.0MQuarter to 31 Mar 2024: revenue $1.9B, net income $216.0MQuarter to 31 Mar 2024: revenue $1.9B, net income $216.0MQuarter to 30 Jun 2024: revenue $1.9B, net income $148.0MQuarter to 30 Jun 2024: revenue $1.9B, net income $148.0MQuarter to 30 Sep 2024: revenue $1.9B, net income $188.0MQuarter to 30 Sep 2024: revenue $1.9B, net income $188.0MQuarter to 31 Dec 2024: revenue $1.8B, net income $95.0MQuarter to 31 Dec 2024: revenue $1.8B, net income $95.0MQuarter to 31 Mar 2025: revenue $1.8B, net income $197.0MQuarter to 31 Mar 2025: revenue $1.8B, net income $197.0MQuarter to 30 Jun 2025: revenue $1.8B, net income $196.0MQuarter to 30 Jun 2025: revenue $1.8B, net income $196.0MQuarter to 30 Sep 2025: revenue $1.8B, net income $171.0MQuarter to 30 Sep 2025: revenue $1.8B, net income $171.0MQuarter to 31 Dec 2025: revenue $1.8B, net income $165.0MQuarter to 31 Dec 2025: revenue $1.8B, net income $165.0MQuarter to 31 Mar 2026: revenue $1.8B, net income $142.0MQuarter to 31 Mar 2026: revenue $1.8B, net income $142.0MQuarter to 30 Jun 2026: revenue $1.9B, net income $114.0MQuarter to 30 Jun 2026: revenue $1.9B, net income $114.0MQuarter to 30 Sep 2026: revenue $1.8B, net income $142.0MQuarter to 30 Sep 2026: revenue $1.8B, net income $142.0M
31 Dec 2021RevenueNet incometallest bar $2.1B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.8B$142.0M
30 Jun 2026$1.9B$114.0M
31 Mar 2026$1.8B$142.0M
31 Dec 2025$1.8B$165.0M
30 Sep 2025$1.8B$171.0M
30 Jun 2025$1.8B$196.0M
31 Mar 2025$1.8B$197.0M
31 Dec 2024$1.8B$95.0M
30 Sep 2024$1.9B$188.0M
30 Jun 2024$1.9B$148.0M
31 Mar 2024$1.9B$216.0M
31 Dec 2023$1.9B$131.0M
30 Sep 2023$2.0B$158.0M
30 Jun 2023$2.1B$163.0M
31 Mar 2023$2.1B$191.0M
31 Dec 2022$2.0B$114.0M
30 Sep 2022$2.0B$106.0M
30 Jun 2022$2.0B$142.0M
31 Mar 2022$1.9B$130.0M
31 Dec 2021$1.8B$67.0M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $7.2B $7.3B
Revenue growthRevenue of the last 12 months compared with the 12 months before. -1.0% +3.1%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $563.0M $659.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $8.79 $10.03
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 23.0% 25.4% 29.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 11.3% 13.2% 4.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 7.8% 9.1% 3.0%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 12.8% 7.5%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $346.0M $546.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $989.0M $915.0M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $1.8B $1.8B
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $786.0M $883.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.39 0.60
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $73.10
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 9.9 20.9
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.77 0.96
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 0.88 1.4
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.2 1.8

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
IngredionINGR (this company) $5.6B9.90.77-1.0%7.8%
POSTPOST $3.5B10.80.42-0.5%3.9%
FreshpetFRPT $3.0B22.82.5+12%10.9%
General MillsGIS $19.1Bloss1.0-4.5%-4.9%
Pilgrims PridePPC $6.8B21.30.37-0.1%1.7%
Campbell'sCPB $7.1B17.60.73-5.0%4.1%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-0.8%

591 13F filers vs 596

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

62.4M shares held by 13F filers (30 Sep 2026) of 62.3M outstanding (4 Nov 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

7.3%

4.6M shares sold short (30 Oct 2026) of 62.3M outstanding (4 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

6.4

4.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-2.4%

4.7M shares sold short in the report before, 4.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

59%

59% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 67%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

-1.3%

$1.8B vs $1.8B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-1.9%

$103.0M vs $105.0M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$200K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

11

11 articles in the last 7 days; its usual week has 3 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

3.7×

11 articles in the last 7 days; its usual week has 3.

Unusual now sharp changes in the last 90 days, compared with its own past

  • New lobbying issue

Price $89.19 on 20 Nov 2026, -16% over 12 months (12-month range $88.53 to $120.41)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $6.0M in the last 12 months (the 12 months before: -$20.4M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 3 published in the last 12 months, -50% on the 12 months before.
Revenue per quarter. Revenue $1.8B in the latest quarter, -1.3% on a year earlier.
Capital spending per quarter. Capital spending $103.0M in the latest quarter, -1.9% on a year earlier.
Institutional holders (13F filers). 591 13F filers reported holding it in the latest 13F quarter, -4.5% on a year earlier.
Lobbying spend. Lobbying spend: $200K published in the last 12 months, 0% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
20 Oct 2026Sharp changeLobbying on a new issue: lobbying on a new issue: FOO (2026-09-30)
20 Aug 20268-K and other filingsDirector or officer change
18 Aug 2026Sharp changeShort interest spike: short interest spike, 4.7M vs usual 2.3M (2026-07-31); 3.6x the same period a year earlier
11 Jun 20268-K and other filingsDirector or officer change
5 May 20268-K and other filingsAsset write-down (impairment)
5 May 20268-K and other filingsRestructuring costs announced
25 Mar 20268-K and other filingsDirector or officer change
23 Mar 20268-K and other filingsDirector or officer change
27 Jan 20268-K and other filingsDirector or officer change
27 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Aug 20258-K and other filingsA major agreement ended
21 Apr 2025Sharp changeLobbying on a new issue: lobbying on a new issue: BUD (2025-03-31)
1 Apr 2025Sharp changeShort interest spike: short interest spike, 2.1M vs usual 816K (2025-03-14); 3.6x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 1.8M vs usual 714K (2025-02-28); 2.8x the same period a year earlier
4 Mar 2025Sharp changeShort interest spike: short interest spike, 1.8M vs usual 676K (2025-02-14); 3.8x the same period a year earlier
25 Feb 2025Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 131.0M vs usual 77.0M (2024-12-31); 1.6x the same period a year earlier
28 Jan 2025Sharp changeShort interest spike: short interest spike, 1.2M vs usual 634K (2025-01-15); 2.8x the same period a year earlier
6 Jan 20258-K and other filingsRestructuring costs announced
6 Jan 20258-K and other filingsAsset write-down (impairment)
27 Aug 2024Sharp changeShort interest spike: short interest spike, 1.1M vs usual 577K (2024-08-15); 1.9x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 1.1M vs usual 566K (2024-07-31); 2.7x the same period a year earlier
25 Jul 20248-K and other filingsDirector or officer change
25 Jul 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 Jul 2024Sharp changeShort interest spike: short interest spike, 1.3M vs usual 557K (2024-06-28); 3.0x the same period a year earlier
27 Feb 20248-K and other filingsDirector or officer change
27 Feb 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Feb 2024Sharp changeMany funds opening a new position: many funds opening a new position, 61 vs usual 41.50 (2023-12-31); 1.1x the same period a year earlier
6 Feb 2024Lobbying filingnew lobbying registration (TORREY ADVISORY GROUP (FORMERLY MICHAEL TORREY ASSOCIATES, LLC))
18 Sep 20238-K and other filingsDirector or officer change
18 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Aug 2023Sharp changeMany funds opening a new position: many funds opening a new position, 63 vs usual 40.50 (2023-06-30); 1.5x the same period a year earlier
23 May 20238-K and other filingsDirector or officer change
3 Apr 20238-K and other filingsDirector or officer change
3 Apr 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Jan 2023Lobbying filinglobbying engagement terminated (DUTKO WORLDWIDE, LLC)
13 Jan 20228-K and other filingsDirector or officer change
16 Dec 20218-K and other filingsDirector or officer change
Insider net buying (open market)
Month from 1 Feb 2022: $429K published
Month from 1 Mar 2022: -$180 published
Month from 1 Jun 2022: -$167K published
Month from 1 Oct 2022: -$8.9 published
Month from 1 Nov 2022: -$274K published
Month from 1 Feb 2023: -$271 published
Month from 1 Mar 2023: -$714K published
Month from 1 Apr 2023: -$3.9 published
Month from 1 May 2023: -$318K published
Month from 1 Jun 2023: -$812K published
Month from 1 Jul 2023: -$550K published
Month from 1 Sep 2023: $296K published
Month from 1 Oct 2023: -$38.8 published
Month from 1 Dec 2023: -$47.8 published
Month from 1 Jan 2024: -$106 published
Month from 1 Feb 2024: -$273K published
Month from 1 Mar 2024: -$6.6M published
Month from 1 Apr 2024: -$84.1 published
Month from 1 May 2024: -$1.3M published
Month from 1 Jun 2024: -$3.2M published
Month from 1 Jul 2024: -$24.2 published
Month from 1 Aug 2024: -$991K published
Month from 1 Sep 2024: -$3.0M published
Month from 1 Oct 2024: -$72K published
Month from 1 Nov 2024: -$1.6M published
Month from 1 Dec 2024: -$8.1M published
Month from 1 Feb 2025: -$6.4M published
Month from 1 Apr 2025: -$42.5 published
Month from 1 May 2025: -$1.2M published
Month from 1 Jul 2025: -$22 published
Month from 1 Aug 2025: -$4.7M published
Month from 1 Oct 2025: -$58.5 published
Month from 1 Dec 2025: -$61.4 published
Month from 1 Feb 2026: -$5.7M published
Month from 1 Mar 2026: -$42K published
Month from 1 Apr 2026: -$83.4 published
Month from 1 Aug 2026: -$170K published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 1 published
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Oct 2022: 1 published
Quarter from 1 Jan 2024: 2 published
Quarter from 1 Apr 2024: 2 published
Quarter from 1 Jul 2024: 3 published
Quarter from 1 Oct 2024: 2 published
Quarter from 1 Jan 2025: 1 published
Quarter from 1 Jul 2025: 3 published
Quarter from 1 Oct 2025: 2 published
Quarter from 1 Jan 2026: 1 published
Quarter from 1 Jul 2026: 1 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $1.8B, +10% on a year earlier; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $1.9B, +17% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $2.0B, +16% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $2.0B, +15% on a year earlier; public on 8 Nov 2022
Quarter ended 31 Dec 2022: $2.0B, +13% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $2.1B, +13% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $2.1B, +1.2% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $2.0B, +0.5% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $1.9B, -3.3% on a year earlier; public on 22 Feb 2024
Quarter ended 31 Mar 2024: $1.9B, -12% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $1.9B, -9.2% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $1.9B, -8.0% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $1.8B, -6.3% on a year earlier; public on 21 Feb 2025
Quarter ended 31 Mar 2025: $1.8B, -3.7% on a year earlier; public on 10 May 2025
Quarter ended 30 Jun 2025: $1.8B, -2.4% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $1.8B, -2.9% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $1.8B, -2.4% on a year earlier; public on 18 Feb 2026
Quarter ended 31 Mar 2026: $1.8B, -1.2% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $1.9B, +0.9% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $1.8B, -1.3% on a year earlier; public on 7 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2021: $65.0M; public on 7 May 2022
Quarter ended 30 Jun 2021: $52.0M; public on 10 Aug 2022
Quarter ended 30 Sep 2021: $86.0M; public on 8 Nov 2022
Quarter ended 31 Dec 2021: $97.0M; public on 23 Feb 2022
Quarter ended 31 Mar 2022: $85.0M, +31% on a year earlier; public on 7 May 2022
Quarter ended 30 Jun 2022: $59.0M, +13% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $59.0M, -31% on a year earlier; public on 8 Nov 2022
Quarter ended 31 Dec 2022: $97.0M, 0% on a year earlier; public on 22 Feb 2023
Quarter ended 31 Mar 2023: $76.0M, -11% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $78.0M, +32% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $79.0M, +34% on a year earlier; public on 8 Nov 2023
Quarter ended 31 Dec 2023: $83.0M, -14% on a year earlier; public on 22 Feb 2024
Quarter ended 31 Mar 2024: $65.0M, -14% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $55.0M, -29% on a year earlier; public on 9 Aug 2024
Quarter ended 30 Sep 2024: $50.0M, -37% on a year earlier; public on 9 Nov 2024
Quarter ended 31 Dec 2024: $131.0M, +58% on a year earlier; public on 21 Feb 2025
Quarter ended 31 Mar 2025: $92.0M, +42% on a year earlier; public on 10 May 2025
Quarter ended 30 Jun 2025: $101.0M, +84% on a year earlier; public on 12 Aug 2025
Quarter ended 30 Sep 2025: $105.0M, +110% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Mar 2026: $110.0M, +20% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $100.0M, -1.0% on a year earlier; public on 8 Aug 2026
Quarter ended 30 Sep 2026: $103.0M, -1.9% on a year earlier; public on 7 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 418; public on 14 Feb 2022
31 Mar 2022 report: 424; public on 16 May 2022
30 Jun 2022 report: 426; public on 15 Aug 2022
30 Sep 2022 report: 396; public on 14 Nov 2022
31 Dec 2022 report: 437; public on 14 Feb 2023
31 Mar 2023 report: 441; public on 15 May 2023
30 Jun 2023 report: 453; public on 14 Aug 2023
30 Sep 2023 report: 443; public on 14 Nov 2023
31 Dec 2023 report: 486; public on 14 Feb 2024
31 Mar 2024 report: 521; public on 15 May 2024
30 Jun 2024 report: 523; public on 14 Aug 2024
30 Sep 2024 report: 573; public on 14 Nov 2024
31 Dec 2024 report: 626; public on 14 Feb 2025
31 Mar 2025 report: 627; public on 15 May 2025
30 Jun 2025 report: 646; public on 14 Aug 2025
30 Sep 2025 report: 619; public on 14 Nov 2025
31 Dec 2025 report: 617; public on 17 Feb 2026
31 Mar 2026 report: 639; public on 15 May 2026
30 Jun 2026 report: 596; public on 14 Aug 2026
30 Sep 2026 report: 591; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Apr 2024: $50K published
Quarter from 1 Jul 2024: $50K published
Quarter from 1 Oct 2024: $50K published
Quarter from 1 Jan 2025: $50K published
Quarter from 1 Apr 2025: $50K published
Quarter from 1 Jul 2025: $50K published
Quarter from 1 Oct 2025: $50K published
Quarter from 1 Jan 2026: $50K published
Quarter from 1 Apr 2026: $50K published
Quarter from 1 Jul 2026: $50K published
Quarter from 1 Oct 2026: $50K published

What is unusual now

  • Made public in the last 90 days: it lobbying on a new issue.
  • Short interest spike: had 4.7M shares sold short in the 31 Jul 2026 report, 3.6× the same report last year Public on 12 Aug 2026.
  • Lobbying on a new issue: lobbying on a new issue Public on 20 Oct 2026.
  • Insider net buying (open market): Insiders sold a net $6.0M in the last 12 months (the 12 months before: -$20.4M).

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 6 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
6 Aug 2026David B FischerDirectorSell1,662$102.31$170KForm 4
2 Apr 2026Jorge A. UribeDirectorSell1$112.66$83.4Form 4
19 Mar 2026Davida Marie GableVP Corp. Controller, FinanceSell375$112.44$42KForm 4
19 Feb 2026Larry FernandesSVP, Chief Comm & Sust OfficerSellplanned in advance (10b5-1)1,125$116.55$131KForm 4
19 Feb 2026James P. ZalliePresident and CEOSellplanned in advance (10b5-1)9,958$116.55$1.2MForm 4
12 Feb 2026Larry FernandesSVP, Chief Comm & Sust OfficerSellplanned in advance (10b5-1)3,630$118.40$430KForm 4
12 Feb 2026James P. ZalliePresident and CEOSellplanned in advance (10b5-1)33,597$119.66$4.0MForm 4
9 Dec 2025Jorge A. UribeDirectorSell1$107.70$61.4Form 4

591 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 59 opened a position, 72 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.6.9M11.1%$659.6M+350K+5.4%
Vanguard Portfolio Management LLC4.9M7.81%$466.2M-17K-0.3%
Dimensional Fund Advisors LP3.5M5.63%$335.9M+149K+4.4%
Vanguard Capital Management LLC2.8M4.55%$271.4M-7,508-0.3%
State Street Corp2.2M3.54%$211.2M-26K-1.2%
LSV Asset Management2.2M3.49%-92K-4.1%
American Century Companies Inc2.1M3.37%$201.1M+863K+70%
First Trust Advisors LP1.5M2.47%$147.2M+154K+11%
Yacktman Asset Management LP1.5M2.39%$142.7M+18K+1.2%
Brandes Investment Partners, LP1.5M2.38%$142.2M+257K+21%

Company events

All 49 company events

In 12 months: 5 director or officer changes, 2 major agreements, 1 restructuring, 1 write-down. Results releases and routine reports are left out.

FiledWhat happenedSource
20 Aug 2026Director or officer change8-K
25 Jun 2026Signed a major agreementSame filing: took on new debt8-K
11 Jun 2026Director or officer change8-K
9 Jun 2026Signed a major agreementSame filing: took on new debt8-K
5 May 2026Restructuring costs announced; Asset write-down (impairment)8-K
25 Mar 2026Director or officer change8-K
23 Mar 2026Director or officer change8-K
27 Jan 2026Director or officer change8-K

Reported lobbying spend: $50K in Q3 2026, $50K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jan 2024NewTorrey Advisory Group (Formerly Michael Torrey Associates, LLC)for Ingredion IncorporatedTrade, sustainability and plant-based product issues.FOO, Trade, Agriculture, EnvironmentFiling
31 Dec 2022EndedDutko Worldwide, LLCfor Purecircle USA Inc.Not statedFiling
30 Jun 2017EndedHogan Lovells Cadwalader US LLP (Fka Hogan Lovells US LLP)for Purecircle USA IncNot statedFiling
12 Sep 2016NewHogan Lovells Cadwalader US LLP (Fka Hogan Lovells US LLP)for Purecircle USA IncAdvise PureCircle USA, Inc. on release of detained shipments by Customs and removal from the withhold release order on stevia imports.TradeFiling
1 Jul 2016NewDutko Worldwide, LLCfor Purecircle USA Inc.Trade Enforcement IssuesTradeFiling

The 5 newest of 180 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

25 Feb 2025confirmed

Confirmed across sources Filings + Financials and Lobbying and Short interest and volume

Ingredion (INGR): spent $131.0M on capital projects in the quarter ended 31 Dec 2024, 1.6× the same quarter last year; it also had 1.8M shares sold short in the 14 Feb 2025 report, 3.8× the same report last year; and it lobbying on a new issue. Three unrelated kinds of activity within 82 days.

  • Short interest and volume: Short interest spike, became public on 28 Jan 2025
  • Financials: Quarterly capital spending jump, became public on 25 Feb 2025
  • Short interest and volume: Short interest spike, became public on 27 Feb 2025
  • Short interest and volume: Short interest spike, became public on 12 Mar 2025
  • Short interest and volume: Short interest spike, became public on 26 Mar 2025
  • Lobbying: Lobbying on a new issue, became public on 21 Apr 2025
2022-12-31: $97.0M2023-03-31: $76.0M2023-06-30: $78.0M2023-09-30: $79.0M2023-12-31: $83.0M2024-03-31: $65.0M2024-06-30: $55.0M2024-09-30: $50.0M2024-12-31: $131.0M
The quarter ended 31 Dec 2024 against the 8 quarters before it. this quarterearliernormal: $77.0M
See the evidence (6 changes)

Short interest and volume: Short interest spike became public on 28 Jan 2025

Ingredion had 1.2M shares sold short in the 15 Jan 2025 report, 2.8× the same report last year.

This period
1.2M (the 15 Jan 2025 report)
Normal report (median of 24 earlier)
634K
Typical spread (median absolute deviation)
116K
How far from its usual level
+3.5
Same report last year
436K
History used
2,574 days
2024-01-12: 436K2024-01-31: 501K2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M
the 15 Jan 2025 report24 earlier reportsnormal: 634K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly capital spending jump became public on 25 Feb 2025

Ingredion spent $131.0M on capital projects in the quarter ended 31 Dec 2024, 1.6× the same quarter last year.

This period
$131.0M (the quarter ended 31 Dec 2024)
Normal quarter (median of 8 earlier)
$77.0M
Typical spread (median absolute deviation)
$9.0M
How far from its usual level
+4.0
Same quarter last year
$83.0M
History used
3,563 days
2022-12-31: $97.0M2023-03-31: $76.0M2023-06-30: $78.0M2023-09-30: $79.0M2023-12-31: $83.0M2024-03-31: $65.0M2024-06-30: $55.0M2024-09-30: $50.0M2024-12-31: $131.0M
the quarter ended 31 Dec 20248 earlier quartersnormal: $77.0M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 27 Feb 2025

Ingredion had 1.8M shares sold short in the 14 Feb 2025 report, 3.8× the same report last year.

This period
1.8M (the 14 Feb 2025 report)
Normal report (median of 24 earlier)
676K
Typical spread (median absolute deviation)
158K
How far from its usual level
+4.9
Same report last year
482K
History used
2,604 days
2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M
the 14 Feb 2025 report24 earlier reportsnormal: 676K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 12 Mar 2025

Ingredion had 1.8M shares sold short in the 28 Feb 2025 report, 2.8× the same report last year.

This period
1.8M (the 28 Feb 2025 report)
Normal report (median of 24 earlier)
714K
Typical spread (median absolute deviation)
183K
How far from its usual level
+4.2
Same report last year
653K
History used
2,618 days
2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M2025-02-28: 1.8M
the 28 Feb 2025 report24 earlier reportsnormal: 714K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Mar 2025

Ingredion had 2.1M shares sold short in the 14 Mar 2025 report, 3.6× the same report last year.

This period
2.1M (the 14 Mar 2025 report)
Normal report (median of 24 earlier)
816K
Typical spread (median absolute deviation)
227K
How far from its usual level
+3.7
Same report last year
575K
History used
2,632 days
2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M2025-02-28: 1.8M2025-03-14: 2.1M
the 14 Mar 2025 report24 earlier reportsnormal: 816K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Lobbying: Lobbying on a new issue became public on 21 Apr 2025

Ingredion lobbying on a new issue.

New
['BUD']
Rule
only points whose every posting (and value revision) is at or before as_of
Field
issue_codes
Metric
lobbying.filings_count
Point id
11559992

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 20 Oct 2026Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['FOO']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    9634698
  2. 20 Aug 2026Filings record

    Director or officer change

  3. 12 Aug 2026Short interest and volume change

    had 4.7M shares sold short in the 31 Jul 2026 report, 3.6× the same report last year.

    Same report last year: 1.3M; its normal report is 2.3M.

    See the evidence
    This period
    4.7M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    2.3M
    Typical spread (median absolute deviation)
    417K
    How far from its usual level
    +3.9
    Same report last year
    1.3M
    History used
    3,136 days
    2025-07-31: 1.3M2025-08-15: 1.5M2025-08-29: 1.9M2025-09-15: 2.0M2025-09-30: 2.1M2025-10-15: 2.0M2025-10-31: 1.8M2025-11-14: 1.6M2025-11-28: 1.7M2025-12-15: 1.9M2025-12-31: 2.2M2026-01-15: 2.3M2026-01-30: 2.4M2026-02-13: 2.3M2026-02-27: 2.7M2026-03-13: 2.5M2026-03-31: 2.8M2026-04-15: 2.6M2026-04-30: 2.8M2026-05-15: 3.2M2026-05-29: 3.3M2026-06-15: 3.6M2026-06-30: 4.1M2026-07-15: 4.6M2026-07-31: 4.7M
    the 31 Jul 2026 report24 earlier reportsnormal: 2.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 11 Jun 2026Filings record

    Director or officer change

  5. 5 May 2026Filings record

    Asset write-down (impairment)

  6. 5 May 2026Filings record

    Restructuring costs announced

  7. 25 Mar 2026Filings record

    Director or officer change

  8. 23 Mar 2026Filings record

    Director or officer change

  9. 27 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 27 Jan 2026Filings record

    Director or officer change

  11. 28 Aug 2025Filings record

    A major agreement ended

  12. 21 Apr 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['BUD']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    11559992
  13. 26 Mar 2025Short interest and volume change

    had 2.1M shares sold short in the 14 Mar 2025 report, 3.6× the same report last year.

    Same report last year: 575K; its normal report is 816K.

    See the evidence
    This period
    2.1M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    816K
    Typical spread (median absolute deviation)
    227K
    How far from its usual level
    +3.7
    Same report last year
    575K
    History used
    2,632 days
    2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M2025-02-28: 1.8M2025-03-14: 2.1M
    the 14 Mar 2025 report24 earlier reportsnormal: 816K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 12 Mar 2025Short interest and volume change

    had 1.8M shares sold short in the 28 Feb 2025 report, 2.8× the same report last year.

    Same report last year: 653K; its normal report is 714K.

    See the evidence
    This period
    1.8M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    714K
    Typical spread (median absolute deviation)
    183K
    How far from its usual level
    +4.2
    Same report last year
    653K
    History used
    2,618 days
    2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M2025-02-28: 1.8M
    the 28 Feb 2025 report24 earlier reportsnormal: 714K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 27 Feb 2025Short interest and volume change

    had 1.8M shares sold short in the 14 Feb 2025 report, 3.8× the same report last year.

    Same report last year: 482K; its normal report is 676K.

    See the evidence
    This period
    1.8M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    676K
    Typical spread (median absolute deviation)
    158K
    How far from its usual level
    +4.9
    Same report last year
    482K
    History used
    2,604 days
    2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M
    the 14 Feb 2025 report24 earlier reportsnormal: 676K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 25 Feb 2025several at once

    spent $131.0M on capital projects in the quarter ended 31 Dec 2024, 1.6× the same quarter last year; it also had 1.8M shares sold short in the 14 Feb 2025 report, 3.8× the same report last year; and it lobbying on a new issue. Three unrelated kinds of activity within 82 days.

    See the evidence (6 changes)

    Short interest and volume: Short interest spike became public on 28 Jan 2025

    Ingredion had 1.2M shares sold short in the 15 Jan 2025 report, 2.8× the same report last year.

    This period
    1.2M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    634K
    Typical spread (median absolute deviation)
    116K
    How far from its usual level
    +3.5
    Same report last year
    436K
    History used
    2,574 days
    2024-01-12: 436K2024-01-31: 501K2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M
    the 15 Jan 2025 report24 earlier reportsnormal: 634K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Financials: Quarterly capital spending jump became public on 25 Feb 2025

    Ingredion spent $131.0M on capital projects in the quarter ended 31 Dec 2024, 1.6× the same quarter last year.

    This period
    $131.0M (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    $77.0M
    Typical spread (median absolute deviation)
    $9.0M
    How far from its usual level
    +4.0
    Same quarter last year
    $83.0M
    History used
    3,563 days
    2022-12-31: $97.0M2023-03-31: $76.0M2023-06-30: $78.0M2023-09-30: $79.0M2023-12-31: $83.0M2024-03-31: $65.0M2024-06-30: $55.0M2024-09-30: $50.0M2024-12-31: $131.0M
    the quarter ended 31 Dec 20248 earlier quartersnormal: $77.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 27 Feb 2025

    Ingredion had 1.8M shares sold short in the 14 Feb 2025 report, 3.8× the same report last year.

    This period
    1.8M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    676K
    Typical spread (median absolute deviation)
    158K
    How far from its usual level
    +4.9
    Same report last year
    482K
    History used
    2,604 days
    2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M
    the 14 Feb 2025 report24 earlier reportsnormal: 676K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 12 Mar 2025

    Ingredion had 1.8M shares sold short in the 28 Feb 2025 report, 2.8× the same report last year.

    This period
    1.8M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    714K
    Typical spread (median absolute deviation)
    183K
    How far from its usual level
    +4.2
    Same report last year
    653K
    History used
    2,618 days
    2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M2025-02-28: 1.8M
    the 28 Feb 2025 report24 earlier reportsnormal: 714K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Mar 2025

    Ingredion had 2.1M shares sold short in the 14 Mar 2025 report, 3.6× the same report last year.

    This period
    2.1M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    816K
    Typical spread (median absolute deviation)
    227K
    How far from its usual level
    +3.7
    Same report last year
    575K
    History used
    2,632 days
    2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M2025-01-31: 1.4M2025-02-14: 1.8M2025-02-28: 1.8M2025-03-14: 2.1M
    the 14 Mar 2025 report24 earlier reportsnormal: 816K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Lobbying: Lobbying on a new issue became public on 21 Apr 2025

    Ingredion lobbying on a new issue.

    New
    ['BUD']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    11559992

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  17. 25 Feb 2025Financials change

    spent $131.0M on capital projects in the quarter ended 31 Dec 2024, 1.6× the same quarter last year.

    Same quarter last year: $83.0M; its normal quarter is $77.0M.

    See the evidence
    This period
    $131.0M (the quarter ended 31 Dec 2024)
    Normal quarter (median of 8 earlier)
    $77.0M
    Typical spread (median absolute deviation)
    $9.0M
    How far from its usual level
    +4.0
    Same quarter last year
    $83.0M
    History used
    3,563 days
    2022-12-31: $97.0M2023-03-31: $76.0M2023-06-30: $78.0M2023-09-30: $79.0M2023-12-31: $83.0M2024-03-31: $65.0M2024-06-30: $55.0M2024-09-30: $50.0M2024-12-31: $131.0M
    the quarter ended 31 Dec 20248 earlier quartersnormal: $77.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  18. 28 Jan 2025Short interest and volume change

    had 1.2M shares sold short in the 15 Jan 2025 report, 2.8× the same report last year.

    Same report last year: 436K; its normal report is 634K.

    See the evidence
    This period
    1.2M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    634K
    Typical spread (median absolute deviation)
    116K
    How far from its usual level
    +3.5
    Same report last year
    436K
    History used
    2,574 days
    2024-01-12: 436K2024-01-31: 501K2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M2024-08-30: 950K2024-09-13: 884K2024-09-30: 747K2024-10-15: 613K2024-10-31: 605K2024-11-15: 559K2024-11-29: 518K2024-12-13: 1.0M2024-12-31: 1.0M2025-01-15: 1.2M
    the 15 Jan 2025 report24 earlier reportsnormal: 634K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 6 Jan 2025Filings record

    Asset write-down (impairment)

  20. 6 Jan 2025Filings record

    Restructuring costs announced

  21. 27 Aug 2024Short interest and volume change

    had 1.1M shares sold short in the 15 Aug 2024 report, 1.9× the same report last year.

    Same report last year: 557K; its normal report is 577K.

    See the evidence
    This period
    1.1M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    577K
    Typical spread (median absolute deviation)
    87K
    How far from its usual level
    +3.9
    Same report last year
    557K
    History used
    2,421 days
    2023-08-15: 557K2023-08-31: 757K2023-09-15: 767K2023-09-29: 556K2023-10-13: 481K2023-10-31: 499K2023-11-15: 496K2023-11-30: 421K2023-12-15: 637K2023-12-29: 371K2024-01-12: 436K2024-01-31: 501K2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M2024-08-15: 1.1M
    the 15 Aug 2024 report24 earlier reportsnormal: 577K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 10 Aug 2024Short interest and volume change

    had 1.1M shares sold short in the 31 Jul 2024 report, 2.7× the same report last year.

    Same report last year: 427K; its normal report is 566K.

    See the evidence
    This period
    1.1M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    566K
    Typical spread (median absolute deviation)
    84K
    How far from its usual level
    +4.6
    Same report last year
    427K
    History used
    2,406 days
    2023-07-31: 427K2023-08-15: 557K2023-08-31: 757K2023-09-15: 767K2023-09-29: 556K2023-10-13: 481K2023-10-31: 499K2023-11-15: 496K2023-11-30: 421K2023-12-15: 637K2023-12-29: 371K2024-01-12: 436K2024-01-31: 501K2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M2024-07-15: 941K2024-07-31: 1.1M
    the 31 Jul 2024 report24 earlier reportsnormal: 566K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 25 Jul 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  24. 25 Jul 2024Filings record

    Director or officer change

  25. 11 Jul 2024Short interest and volume change

    had 1.3M shares sold short in the 28 Jun 2024 report, 3.0× the same report last year.

    Same report last year: 439K; its normal report is 557K.

    See the evidence
    This period
    1.3M (the 28 Jun 2024 report)
    Normal report (median of 24 earlier)
    557K
    Typical spread (median absolute deviation)
    75K
    How far from its usual level
    +6.9
    Same report last year
    439K
    History used
    2,373 days
    2023-06-30: 439K2023-07-14: 563K2023-07-31: 427K2023-08-15: 557K2023-08-31: 757K2023-09-15: 767K2023-09-29: 556K2023-10-13: 481K2023-10-31: 499K2023-11-15: 496K2023-11-30: 421K2023-12-15: 637K2023-12-29: 371K2024-01-12: 436K2024-01-31: 501K2024-02-15: 482K2024-02-29: 653K2024-03-15: 575K2024-03-28: 682K2024-04-15: 579K2024-04-30: 615K2024-05-15: 670K2024-05-31: 518K2024-06-14: 608K2024-06-28: 1.3M
    the 28 Jun 2024 report24 earlier reportsnormal: 557K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 27 Feb 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  27. 27 Feb 2024Filings record

    Director or officer change

  28. 14 Feb 2024Institutional holdings change

    saw 61 13F filers open a new position in the quarter ended 31 Dec 2023, 1.1× the same quarter last year.

    Same quarter last year: 55; its normal quarter is 41.5.

    See the evidence
    This period
    61 (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    41.5
    Typical spread (median absolute deviation)
    1.5
    How far from its usual level
    +4.7
    Same quarter last year
    55
    History used
    3,744 days
    2021-12-31: 422022-03-31: 412022-06-30: 432022-09-30: 402022-12-31: 552023-03-31: 322023-06-30: 632023-09-30: 412023-12-31: 61
    the quarter ended 31 Dec 20238 earlier quartersnormal: 41.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  29. 6 Feb 2024Lobbying record

    INGREDION INCORPORATED: new lobbying registration (TORREY ADVISORY GROUP (FORMERLY MICHAEL TORREY ASSOCIATES, LLC)) (dated 1 Jan 2024)

  30. 18 Sep 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  31. 18 Sep 2023Filings record

    Director or officer change

  32. 6 Sep 2023Insiders record

    Seip David Eric (SVP, Global Ops and CSCO) bought 3,000 shares of INGR ($295,500) (dated 5 Sep 2023)

  33. 14 Aug 2023Institutional holdings change

    saw 63 13F filers open a new position in the quarter ended 30 Jun 2023, 1.5× the same quarter last year.

    Same quarter last year: 43; its normal quarter is 40.5.

    See the evidence
    This period
    63 (the quarter ended 30 Jun 2023)
    Normal quarter (median of 8 earlier)
    40.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +5.6
    Same quarter last year
    43
    History used
    3,560 days
    2021-06-30: 212021-09-30: 392021-12-31: 422022-03-31: 412022-06-30: 432022-09-30: 402022-12-31: 552023-03-31: 322023-06-30: 63
    the quarter ended 30 Jun 20238 earlier quartersnormal: 40.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  34. 23 May 2023Filings record

    Director or officer change

  35. 3 Apr 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  36. 3 Apr 2023Filings record

    Director or officer change

  37. 11 Jan 2023Lobbying record

    PURECIRCLE USA INC.: lobbying engagement terminated (DUTKO WORLDWIDE, LLC) (dated 31 Dec 2022)

  38. 9 Feb 2022Insiders record

    Seip David Eric (SVP, Global Ops & CSCO) bought 5,000 shares of INGR ($429,500) (dated 8 Feb 2022)

  39. 13 Jan 2022Filings record

    Director or officer change

  40. 16 Dec 2021Filings record

    Director or officer change

Showing the newest 40 of 75 entries; narrow the window or the kind of data to see older ones.

Not listed: 265 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001046257
Ticker
INGR
Domain
ingredion.com
Employer name
Ingredion Incorporated (1 unverified)
Hq location
IL|WESTCHESTER|60154 (1 unverified)
Lobbying client
ingredion
Name
Amishi Drugs and Chemicals Pvt. Ltd, Arrendadora Gefemesa, S.A. de C.V, Bedford Construction Company, Cali Investment LLC and 72 more
Wikidata
Q8273105
Wikipedia
Ingredion
  • DOL H-1B labor condition applications and PERM certifications159 data points17 Feb 2020 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)5 records, 102 data points1 Jul 2016 to 30 Sep 2026
  • SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)159 records6 Jan 2016 to 6 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1062 data points31 Dec 2007 to 4 Nov 2026
  • SEC Form 4 insider transactions150 records, 360 data points9 Feb 2016 to 6 Aug 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026